Cargando…
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Suicidal behavior (SB) represents a major public health issue. Clinical and basic research suggests that SB is a specific entity in psychiatric nosology involving a combination of personality traits, genetic factors, childhood abuse and neuroanatomical abnormalities. The principal risk factor for su...
Autor principal: | Courtet, Philippe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938281/ https://www.ncbi.nlm.nih.gov/pubmed/20856596 http://dx.doi.org/10.2147/NDT.S11774 |
Ejemplares similares
-
Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants – a case series
por: Kirino, Eiji, et al.
Publicado: (2011) -
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Avedisova, Alla, et al.
Publicado: (2009) -
Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017) -
Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010) -
Milnacipran: a unique antidepressant?
por: Kasper, Siegfried, et al.
Publicado: (2010)